Preformulation Studies & API Optimization MCQs With Answer

Introduction

Preformulation Studies & API Optimization MCQs With Answer is designed for M.Pharm students preparing for advanced coursework and exams in pharmaceutical formulation development. This collection focuses on critical preformulation parameters—physical, chemical and biopharmaceutical properties of APIs—that guide formulation strategies and optimization. Questions cover solid-state characterization, solubility/pKa relationships, particle engineering, polymorphism, stability testing, salt and cocrystal selection, and analytical techniques used during preformulation. Each MCQ is crafted to deepen conceptual understanding and application in real-world formulation problems, helping students integrate theory with practical decision-making required for developing stable, effective, and manufacturable drug products.

Q1. What is the primary objective of preformulation studies for a new API?

• To determine clinical efficacy in humans
• To identify physicochemical properties affecting formulation and stability
• To select final excipients and packaging materials
• To perform large-scale manufacturing

Correct Answer: To identify physicochemical properties affecting formulation and stability

Q2. Which technique is most specific for detecting different crystalline polymorphs of an API?

• Differential Scanning Calorimetry (DSC)
• Infrared Spectroscopy (FTIR)
• X-ray Powder Diffraction (XRPD)
• Thermogravimetric Analysis (TGA)

Correct Answer: X-ray Powder Diffraction (XRPD)

Q3. Why is determination of pKa important during preformulation?

• To estimate thermal stability of the API
• To predict ionization state and pH-dependent solubility and permeability
• To calculate molecular weight
• To establish crystal habit

Correct Answer: To predict ionization state and pH-dependent solubility and permeability

Q4. Which parameter best correlates with passive transcellular membrane permeability of a neutral API?

• Melting point
• Log P (octanol-water partition coefficient)
• Hygroscopicity
• Glass transition temperature

Correct Answer: Log P (octanol-water partition coefficient)

Q5. In preformulation, hygroscopicity testing primarily assesses what risk?

• Photodegradation of the API
• Moisture uptake leading to physical/chemical instability and handling issues
• Potential for polymorphic transformation due to heat
• Biopharmaceutical classification

Correct Answer: Moisture uptake leading to physical/chemical instability and handling issues

Q6. Which property is most directly improved by particle size reduction of an API?

• Chemical stability
• Solubility and dissolution rate due to increased surface area
• Polymorphic form
• pKa value

Correct Answer: Solubility and dissolution rate due to increased surface area

Q7. Which analytical method is most appropriate for quantifying residual solvents in an API sample?

• Gas Chromatography (GC)
• Ultraviolet-visible spectroscopy (UV-Vis)
• Dynamic Vapor Sorption (DVS)
• Polarimetry

Correct Answer: Gas Chromatography (GC)

Q8. Salt selection for an ionizable API is primarily used to:

• Change the API molecular weight
• Modify solubility, dissolution rate, and sometimes stability
• Prevent polymorphism forever
• Make API non-ionizable

Correct Answer: Modify solubility, dissolution rate, and sometimes stability

Q9. Which thermal event observed by DSC typically indicates a crystalline melting point?

• Endothermic sharp peak at a defined temperature
• Broad exothermic baseline shift
• Continuous mass loss with temperature
• Small, reversible baseline oscillation

Correct Answer: Endothermic sharp peak at a defined temperature

Q10. A drug that shows higher solubility in its amorphous state than crystalline state is most likely to have what drawback?

• Higher mechanical strength
• Greater risk of physical instability and recrystallization
• Lower initial dissolution rate
• Inability to be compressed into tablets

Correct Answer: Greater risk of physical instability and recrystallization

Q11. The Hansen solubility parameter helps in preformulation primarily to:

• Estimate drug potency
• Predict compatibility and miscibility between API and excipients or solvents
• Measure dissolution in gastric fluid
• Determine enzymatic degradation

Correct Answer: Predict compatibility and miscibility between API and excipients or solvents

Q12. Which preformulation test quantifies particle-size distribution and can indicate potential flow problems?

• Laser diffraction analysis
• pKa titration
• XRPD
• Karl Fischer titration

Correct Answer: Laser diffraction analysis

Q13. In a stability study, observing a new peak in HPLC chromatogram over time most likely indicates:

• An irreversible physical change like pelletization
• Chemical degradation producing impurities or degradation products
• Improved bioavailability
• Change in particle size distribution

Correct Answer: Chemical degradation producing impurities or degradation products

Q14. Cocrystal formation is considered in preformulation to:

• Increase molecular weight and reduce potency
• Enhance solubility, dissolution and sometimes stability without ionic conversion
• Convert API to a salt form
• Guarantee zero hygroscopicity

Correct Answer: Enhance solubility, dissolution and sometimes stability without ionic conversion

Q15. Which property measured by dynamic vapor sorption (DVS) is most relevant for predicting storage behavior?

• Thermal degradation onset
• Moisture sorption isotherm and deliquescence/hygroscopic behavior
• pKa shift with humidity
• Surface charge density

Correct Answer: Moisture sorption isotherm and deliquescence/hygroscopic behavior

Q16. For a weakly basic drug, solubility is generally highest at:

• High pH (alkaline) when deprotonated
• Low pH (acidic) where it is protonated and water-soluble
• Exactly at its pKa value
• Neutral pH only

Correct Answer: Low pH (acidic) where it is protonated and water-soluble

Q17. Which parameter obtained from zeta potential measurement helps predict colloidal stability of a suspending API?

• Particle mean diameter
• Surface charge magnitude indicating electrostatic repulsion
• Moisture content
• Glass transition temperature

Correct Answer: Surface charge magnitude indicating electrostatic repulsion

Q18. Accelerated stability testing (e.g., 40°C/75% RH) is used mainly to:

• Replace long-term clinical trials
• Predict likely degradation pathways and estimate shelf-life trends
• Measure API solubility in buffer
• Determine tablet hardness only

Correct Answer: Predict likely degradation pathways and estimate shelf-life trends

Q19. Supersaturation achieved by amorphous or nano-formulations is beneficial because:

• It ensures permanent higher solubility without stabilization
• It can transiently increase driving force for absorption but requires precipitation inhibition strategies
• It always prevents chemical degradation
• It reduces the need for excipients

Correct Answer: It can transiently increase driving force for absorption but requires precipitation inhibition strategies

Q20. Which combination of techniques is most complementary for confirming identity and solid-state form of an API?

• UV-Vis and pH titration
• XRPD for crystal form and FTIR for molecular interactions
• Karl Fischer and DSC only
• Laser diffraction and gas chromatography

Correct Answer: XRPD for crystal form and FTIR for molecular interactions

Download